Loading...
Please wait, while we are loading the content...
Efectos adversos de la exposición a antirretrovirales en el embarazo, el feto y el recién nacido
| Content Provider | Semantic Scholar |
|---|---|
| Author | Figueroa-Medrano, Laura Patricia Ávila-Figueroa, Carlos |
| Copyright Year | 2002 |
| Abstract | The development and use of antiretroviral therapy in perinatal stage is one of the more important advances in prevention of vertical transmission of VIH infection; nevertheless, its use also represents a risk of adverse effects in the pregnant woman, the product or the newborn child. In the pregnant woman it has been described nausea, vomiting, gestational diabetes and preterm delivery. In the child there is risk for anemia, metabolic disorders, mitochondrial disease and neurodevelopment disorders. Some drugs such as efavirenz, have been associated to CNS malformations, therefore it is not administrated during pregnancy. At this moment, the benefits of using the accepted antiretroviral drugs are higher than the risk of adverse effects. Still, there is uncertainty about short and long term side effects of its use during perinatal stage and about the use of combined therapy in pregnant woman. This paper reviews the knowledge about the use of antiretroviral drugs in pregnant woman, fetal age and newborn child. |
| Starting Page | 175 |
| Ending Page | 181 |
| Page Count | 7 |
| File Format | PDF HTM / HTML |
| Volume Number | 22 |
| Alternate Webpage(s) | http://www.medigraphic.com/pdfs/micro/ei-2002/ei024b.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
